{"id":"W2511121889","doi":"10.1182/blood.v110.11.189.189","title":"Phase II Testing of Lenalidomide Plus Melphalan for Previously Untreated Older Patients with Multiple Myeloma: Toxicity Data from the NCIC CTG MY.11 Trial.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Moncton Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Lenalidomide; Medicine; Neutropenia; Tolerability; Multiple myeloma; Adverse effect; Melphalan; Febrile neutropenia; Internal medicine; Phases of clinical research; Toxicity; Surgery; Oncology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004570472,0.00102201,0.001796483,0.00030922,0.0004132673,0.0009138075,0.001126167,0.001190955,0.00411667],"category_scores_gemma":[0.002442048,0.0003584643,0.001313581,0.0005725725,0.0006568951,0.0006171394,0.0004235992,0.003377493,0.0007051814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001459297,"about_ca_system_score_gemma":0.002180012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001335473,"about_ca_topic_score_gemma":0.005279385,"domain_scores_codex":[0.9985252,0.001065655,0.00007515084,0.0001244691,0.0001060409,0.000103575],"domain_scores_gemma":[0.9971711,0.0006125181,0.0008730717,0.0002062282,0.0001593377,0.0009777258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8299325,0.01717279,0.0114573,0.002038025,0.002673815,0.0003255516,0.0002305475,0.003006323,0.01823046,0.0004798376,0.01912961,0.09532324],"study_design_scores_gemma":[0.6346098,0.3234905,0.02293566,0.000227197,0.001285932,0.0005337565,0.00006107476,0.001084501,0.002784093,0.0004129762,0.01252517,0.00004927906],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9498749,0.01917837,0.001334713,0.003543396,0.0003676905,0.006898621,0.009516842,0.000203383,0.009082091],"genre_scores_gemma":[0.960586,0.005296626,0.003622961,0.003664923,0.0004242999,0.009131024,0.01245145,0.0000667887,0.004755966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004570472,"threshold_uncertainty_score":0.02417123,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07021945872571524,"score_gpt":0.3351190329707618,"score_spread":0.2648995742450466,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}